Scott Koenig - Feb 8, 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
President and CEO, Director
Signature
Beth A. Smith, Attorney-in-fact
Stock symbol
MGNX
Transactions as of
Feb 8, 2025
Transactions value $
$0
Form type
4
Date filed
2/11/2025, 08:28 PM
Previous filing
Oct 9, 2024
Next filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Award $0 +31.7K +4.5% $0.00 735K Feb 8, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -31.7K -33.34% $0.00 63.3K Feb 8, 2025 Common Stock 31.7K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 8, 2024 the reporting person was granted 95,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.